Genetic Disorders tests in Dubai & UAE

Compare available Genetic Disorders tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

136

Listed price range

1,100.00–4,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic Disorders test prices

Showing 121–135 of 136 matching tests.

Genetic Disorders diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-3872 SLC2A2 Gene Fanconi-Bickel Syndrome Test This genetic test analyzes the SLC2A2 gene to identify pathogenic variants associated with Fanconi-Bickel Syndrome.	Whole Blood / Extracted DNA / FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in SLC2A2 gene", "Copy Number Variants (CNVs) in SLC2A2"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected Fanconi-Bickel Syndrome", "Family history of Fanconi-Bickel Syndrome", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 101399-9 ICD-10: E74.09 Clinical summary This genetic test analyzes the SLC2A2 gene to identify pathogenic variants associated with Fanconi-Bickel Syndrome.
TEST-4539 SLC6A5 Gene Hyperekplexia Genetic Test This diagnostic test evaluates the entire coding region of the SLC6A5 gene for pathogenic variants associated with hereditary hyperekplexia.	Whole Blood (EDTA tube), Extracted DNA (≥1µg), or One Drop Blood on FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC6A5 gene", "Point mutations", "Small insertions/deletions", "Copy number variants"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Neonates with suspected hyperekplexia", "Family history of hyperekplexia", "Carrier screening in at-risk families"] Measurement technique Confirm with laboratory Codes LOINC: 86238-7 ICD-10: G25.82 Clinical summary This diagnostic test evaluates the entire coding region of the SLC6A5 gene for pathogenic variants associated with hereditary hyperekplexia.
TEST-6388 SLC6A9 Gene Glycine Encephalopathy with Normal Serum Glycine Genetic Test This test identifies disease-causing variants in the SLC6A9 gene associated with glycine encephalopathy, particularly when serum glycine levels are normal.	Whole Blood, Extracted DNA, or FTA Card (dried blood spot)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC6A9 gene"] Parameters [{"name": "Analytical Sensitivity", "reference_range": ">99%"}] Preparation ["Provide complete clinical history", "Genetic counselling session recommended", "No fasting or medication changes required unless directed by doctor", "Do not collect during acute febrile illness"] Indications ["Suspected glycine encephalopathy with normal serum glycine", "Family history of glycine encephalopathy", "Need for precise molecular diagnosis for management and counselling"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: E72.8, G93.49, Z13.71 Clinical summary This test identifies disease-causing variants in the SLC6A9 gene associated with glycine encephalopathy, particularly when serum glycine levels are normal.
TEST-3209 SMARCAL1 Gene Schimke Immuno‑Osseous Dysplasia Genetic Test (NGS) This test identifies pathogenic variants in the SMARCAL1 gene, confirming a diagnosis of Schimke immuno-osseous dysplasia.	Blood, FTA Card, or Extracted DNA	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SMARCAL1 gene pathogenic variants", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (Indels)", "Copy Number Variants (CNVs)"] Parameters [] Preparation ["No fasting required", "No medication changes needed"] Indications ["Suspected Schimke immuno-osseous dysplasia", "Family history of SIOD", "Genetic counseling for related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q87.8 Clinical summary This test identifies pathogenic variants in the SMARCAL1 gene, confirming a diagnosis of Schimke immuno-osseous dysplasia.
TEST-5821 TAT Gene Tyrosinemia Type 2 (NGS) Genetic Test This test identifies pathogenic variants within the TAT gene, confirming or excluding a diagnosis of Tyrosinemia Type 2.	Whole Blood (EDTA), Extracted DNA, or FTA Card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TAT gene", "Coding exons and flanking intronic regions"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication or dietary therapy"] Indications ["Symptomatic individuals suspected of Tyrosinemia Type 2", "Carrier screening for at-risk family members", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 92643-2 ICD-10: E70.21, E70.20 Clinical summary This test identifies pathogenic variants within the TAT gene, confirming or excluding a diagnosis of Tyrosinemia Type 2.
TEST-5839 TCN2 Gene (Transcobalamin II Deficiency) Genetic Test This genetic test identifies pathogenic variants in the TCN2 gene, which are responsible for Transcobalamin II deficiency.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TCN2 gene", "Vitamin B₁₂ transport function"] Parameters [] Preparation [] Indications ["Suspected Transcobalamin II deficiency", "Positive family history", "Clinical presentation consistent with B₁₂ deficiency"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: E53.8 Clinical summary This genetic test identifies pathogenic variants in the TCN2 gene, which are responsible for Transcobalamin II deficiency.
TEST-2651 TP63 Gene Limb-Mammary Syndrome Genetic Test This genetic test analyzes the TP63 gene to detect mutations associated with limb-mammary syndrome and related disorders.	Peripheral whole blood (EDTA tube)	3 to 4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TP63 gene"] Parameters [] Preparation [] Indications ["Suspected limb-mammary syndrome", "Family history of TP63-related disorders", "Genetic counseling for related conditions"] Measurement technique Confirm with laboratory Codes LOINC: 96613-9 ICD-10: Q87.8 Clinical summary This genetic test analyzes the TP63 gene to detect mutations associated with limb-mammary syndrome and related disorders.
TEST-5420 TPM2 Gene Arthrogryposis, Distal Type 1A Genetic Test This test identifies pathogenic mutations within the TPM2 gene associated with distal arthrogryposis type 1A.	Peripheral whole blood (EDTA tube)	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in the TPM2 gene"] Parameters [] Preparation ["No special fasting required", "Mandatory genetic counseling session prior to sample collection"] Indications ["Suspected distal arthrogryposis type 1A", "Family history of distal arthrogryposis", "Genetic counseling for family planning"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q74.3 Clinical summary This test identifies pathogenic mutations within the TPM2 gene associated with distal arthrogryposis type 1A.
TEST-4318 TRAF3 Gene Susceptibility Test (Herpes-Specific Acute Encephalopathy, Type 5) This test evaluates the TRAF3 gene for variants associated with susceptibility to herpes simplex-triggered acute encephalopathy.	Peripheral whole blood (EDTA)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TRAF3 gene", "Copy-number variations (CNVs) in the TRAF3 locus"] Parameters [] Preparation [] Indications ["Confirmation of molecular diagnosis for TRAF3-related herpes susceptibility", "Guidance for prophylactic antiviral strategies", "Familial risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 95053-1 ICD-10: Z13.79 Clinical summary This test evaluates the TRAF3 gene for variants associated with susceptibility to herpes simplex-triggered acute encephalopathy.
TEST-6163 TSFM Gene Combined Oxidative Phosphorylation Deficiency Type 3 Genetic Test This genetic test evaluates the TSFM gene for mutations associated with Combined Oxidative Phosphorylation Deficiency Type 3 (COXPD3).	Whole Blood (Peripheral)	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TSFM gene", "Coding exons and flanking intronic regions of TSFM"] Parameters [] Preparation ["No specific fasting required.", "Inform the lab of any medications being taken."] Indications ["Suspected Combined Oxidative Phosphorylation Deficiency Type 3 (COXPD3)", "Individuals with clinical features suggestive of mitochondrial disorders"] Measurement technique Confirm with laboratory Codes LOINC: 7907-2 ICD-10: E88.49 Clinical summary This genetic test evaluates the TSFM gene for mutations associated with Combined Oxidative Phosphorylation Deficiency Type 3 (COXPD3).
TEST-5347 TTN Gene Myopathy, Early-Onset with Fatal Cardiomyopathy Genetic Test This genetic test evaluates the entire TTN gene for pathogenic variants associated with early-onset myopathy and fatal cardiomyopathy.	Whole blood (peripheral blood)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TTN gene", "Single-nucleotide variants", "Insertions/deletions", "Copy-number changes"] Parameters [] Preparation [] Indications ["Suspected diagnosis of TTN-related early-onset myopathy with fatal cardiomyopathy", "Family history of TTN-related disorders", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 95403-5 ICD-10: G71.2 Clinical summary This genetic test evaluates the entire TTN gene for pathogenic variants associated with early-onset myopathy and fatal cardiomyopathy.
TEST-3833 UBE3A (15q11) Gene Angelman Syndrome Genetic Test This test evaluates the UBE3A gene for mutations, deletions, or imprinting defects associated with Angelman syndrome.	Whole blood (EDTA tube), extracted genomic DNA, or dried blood spot on an FTA card	21–28 calendar days (3–4 weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["UBE3A gene sequence", "Methylation patterns"] Parameters [] Preparation [] Indications ["Suspected Angelman syndrome based on clinical features", "Developmental delay with specific neurological signs"] Measurement technique Confirm with laboratory Codes LOINC: 61896-3 ICD-10: Q93.5 Clinical summary This test evaluates the UBE3A gene for mutations, deletions, or imprinting defects associated with Angelman syndrome.
TEST-3774 VCP Gene Amyotrophic Lateral Sclerosis Type 14 Genetic Test This test identifies pathogenic variants in the VCP gene associated with autosomal dominant amyotrophic lateral sclerosis type 14.	Peripheral whole blood (EDTA)	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in VCP gene", "Point mutations", "Small indels", "Copy number variations"] Parameters [] Preparation ["No fasting required", "No special preparation needed"] Indications ["Suspected diagnosis of Amyotrophic Lateral Sclerosis Type 14", "Genetic counselling for families with ALS-14", "Confirmation of clinical diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 97934-0 ICD-10: G12.21, G12.29 Clinical summary This test identifies pathogenic variants in the VCP gene associated with autosomal dominant amyotrophic lateral sclerosis type 14.
TEST-5362 VPS33B Gene Analysis (Next-Generation Sequencing) for Arthrogryposis, Renal Dysfunction, and Cholestasis Type 1 (ARC Syndrome) Test This diagnostic test evaluates the VPS33B gene for mutations associated with Arthrogryposis, Renal dysfunction, and Cholestasis type 1 (ARC syndrome).	Whole blood (peripheral), extracted DNA, or dried blood spot on FTA card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["VPS33B gene sequence", "Variants in exons and flanking intronic regions"] Parameters [] Preparation [] Indications ["Suspected ARC syndrome based on clinical presentation", "Family history of ARC syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 82439-2 ICD-10: Q87.8 Clinical summary This diagnostic test evaluates the VPS33B gene for mutations associated with Arthrogryposis, Renal dysfunction, and Cholestasis type 1 (ARC syndrome).
TEST-3906 WDPCP Gene Bardet‑Biedl Syndrome Type 15 Genetic Test This test evaluates the WDPCP gene for mutations associated with Bardet‑Biedl syndrome type 15.	Peripheral whole blood (EDTA) or buccal swab; FTA card acceptable for neonates	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["WDPCP gene sequence", "Copy Number Variants (CNVs) in WDPCP gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Clinical suspicion of Bardet‑Biedl syndrome type 15", "Family history of Bardet‑Biedl syndrome", "Need for genetic confirmation for diagnosis and management"] Measurement technique Confirm with laboratory Codes LOINC: 21612-7 ICD-10: Q87.89 Clinical summary This test evaluates the WDPCP gene for mutations associated with Bardet‑Biedl syndrome type 15.

Category overview

Genetic Disorders: overview

Understanding your family's risk for specific hereditary conditions empowers you to make proactive, highly informed health and reproductive decisions. As a core pillar of our advanced Genetics department, comprehensive testing for Genetic Disorders evaluates your DNA for a curated selection of mutations known to cause distinct, multi-system hereditary conditions. Utilizing state-of-the-art sequencing technology, this empowering molecular screening provides the critical clarity needed to assess carrier status and diagnostic risks, safely guiding informed family planning, proactive medical interventions, and specialized reproductive counseling. Widely respected for compassionate diagnostic excellence among premier diagnostic labs in Dubai and the UAE, DNA Labs ensures strict patient confidentiality, uncompromising analytical accuracy, and rapid, dependable reporting. Safeguard your family’s future—book your genetic disorders testing in UAE, arrange a comfortable clinic or home sample collection, or connect with our specialized medical team.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.